Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice.
- DOI
- 10.1038/s44324-026-00119-z
- Published
- 2026 Aug 5
- Container
- npj metabolic health and disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s44324-026-00119-z,
title = {Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice.},
author = {Young M and Dambure S and Cullen F and Jarrah K and McClements L and Ramchunder Z and Aksentijevic D},
year = {2026},
journal = {npj metabolic health and disease},
doi = {10.1038/s44324-026-00119-z},
url = {https://doi.org/10.1038/s44324-026-00119-z}
}RIS
TY - JOUR TI - Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice. AU - Young M AU - Dambure S AU - Cullen F AU - Jarrah K AU - McClements L AU - Ramchunder Z AU - Aksentijevic D PY - 2026 JO - npj metabolic health and disease DO - 10.1038/s44324-026-00119-z UR - https://doi.org/10.1038/s44324-026-00119-z ER -
APA
M, Y., S, D., F, C., K, J., L, M., Z, R., & D, A. (2026). Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice.. npj metabolic health and disease. https://doi.org/10.1038/s44324-026-00119-z
Source records
- pubmed · retrieved 2026-09-26T21:05:23.365Z
- europe-pmc · retrieved 2026-09-26T21:05:23.380Z
- doaj · retrieved 2026-09-26T21:05:23.373Z